John Ahern is back at the company he ran for nine years, just one year after giving up his board seat and resigning his post as CEO.
NMT Medical Inc. (NSDQ:NMTI), a Boston-based device company developing implants that allow interventional cardiologists to treat structural heart disease through catheter-based procedures, said it is bringing Ahern back as a member of the company’s board. His addition means the company will increase the number of seats on its board to seven.